Personalis (PSNL) News Today

$1.26
-0.03 (-2.33%)
(As of 04/22/2024 ET)
SourceHeadline
MarketBeat logoNeedham & Company LLC Reiterates "Buy" Rating for Personalis (NASDAQ:PSNL)
americanbankingnews.com - April 13 at 6:16 AM
marketbeat.com logoPersonalis (NASDAQ:PSNL) Given Buy Rating at Needham & Company LLC
marketbeat.com - April 11 at 8:32 AM
investing.com logoCathie Wood's ARK makes major moves in Tesla stock, sells Robinhood
investing.com - April 2 at 7:34 AM
investing.com logoCathie Wood's ARK buys over $14M in Tesla stock, sells Coinbase in latest trades
investing.com - March 29 at 6:18 AM
businesswire.com logoPersonalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
businesswire.com - March 28 at 4:01 PM
businesswire.com logoData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
businesswire.com - March 28 at 9:00 AM
marketbeat.com logoARK Investment Management LLC Increases Stock Position in Personalis, Inc. (NASDAQ:PSNL)
marketbeat.com - March 27 at 11:16 AM
finance.yahoo.com logoPersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
finance.yahoo.com - March 26 at 12:36 PM
businesswire.com logoPersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com - March 19 at 4:43 PM
finance.yahoo.com logoPSNL Apr 2024 2.500 put
finance.yahoo.com - March 16 at 10:27 AM
finance.yahoo.com logoPSNL Apr 2024 7.500 call
finance.yahoo.com - March 6 at 7:28 PM
markets.businessinsider.com logoBuy Rating Affirmed: Personalis’s Strategic Advances and Financial Health Signal Promising Growth in 2024
markets.businessinsider.com - March 4 at 2:19 PM
markets.businessinsider.com logoBuy Rating Affirmed for Personalis Amidst Strategic Partnerships and Revenue Growth Prospects
markets.businessinsider.com - March 1 at 4:50 PM
seekingalpha.com logoPersonalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 1 at 6:49 AM
uk.finance.yahoo.com logoPersonalis, Inc. (PSNL)
uk.finance.yahoo.com - February 29 at 10:45 PM
finance.yahoo.com logoPersonalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 12:44 PM
marketbeat.com logoNeedham & Company LLC Boosts Personalis (NASDAQ:PSNL) Price Target to $3.50
marketbeat.com - February 29 at 8:23 AM
benzinga.com logoPersonalis: Q4 Earnings Insights
benzinga.com - February 28 at 9:30 PM
finance.yahoo.com logoPersonalis Reports Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 28 at 9:30 PM
markets.businessinsider.com logoWhat Wall Street expects from Personalis's earnings
markets.businessinsider.com - February 27 at 7:23 PM
finance.yahoo.com logoPersonalis to Announce Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 14 at 7:41 PM
businesswire.com logoPersonalis to Announce Fourth Quarter and Full Year 2023 Financial Results
businesswire.com - February 14 at 4:01 PM
finance.yahoo.com logoPersonalis to Participate at Upcoming Investor Conferences
finance.yahoo.com - January 31 at 7:14 PM
markets.businessinsider.com logoPersonalis, ClearNote Health Join Hands To Advance Epigenomic Technology
markets.businessinsider.com - January 30 at 1:11 PM
finance.yahoo.com logoPersonalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
finance.yahoo.com - January 30 at 1:11 PM
finance.yahoo.com logoPersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - January 22 at 12:54 PM
finance.yahoo.com logoPersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
finance.yahoo.com - January 16 at 11:35 AM
uk.investing.com logoPersonalis reports 18% Q4 revenue growth, eyes 2026 runway
uk.investing.com - January 7 at 7:30 PM
markets.businessinsider.com logoBuy Rating for Personalis Amid Strong Growth and Promising VA MVP Developments
markets.businessinsider.com - January 6 at 6:28 PM
markets.businessinsider.com logoPersonalis Expects Q4 Revenue To Grow 18%
markets.businessinsider.com - January 5 at 4:50 PM
marketbeat.com logoPersonalis' (PSNL) Buy Rating Reiterated at Needham & Company LLC
marketbeat.com - January 5 at 1:46 PM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Personalis (PSNL)
markets.businessinsider.com - January 3 at 10:28 AM
finance.yahoo.com logoEven With A 37% Surge, Cautious Investors Are Not Rewarding Personalis, Inc.'s (NASDAQ:PSNL) Performance Completely
finance.yahoo.com - December 18 at 8:32 AM
finance.yahoo.com logoPersonalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
finance.yahoo.com - December 4 at 1:19 PM
bizjournals.com logoEast Bay cancer test company to shed another 65 jobs
bizjournals.com - December 1 at 10:33 PM
msn.com logoCancer test developer Personalis to cut 65 jobs to reduce costs
msn.com - December 1 at 5:32 PM
finance.yahoo.com logoPersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
finance.yahoo.com - November 28 at 9:02 PM
benzinga.com logoMyriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
benzinga.com - November 16 at 5:48 PM
markets.businessinsider.com logoPromising Financial Performance and Product Launch Bolster Buy Rating for Personalis
markets.businessinsider.com - November 9 at 3:31 PM
finance.yahoo.com logoPersonalis, Inc. (NASDAQ:PSNL) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 8 at 6:35 PM
msn.com logoPersonalis GAAP EPS of -$0.60 misses by $0.08, revenue of $18.2M beats by $1.22M
msn.com - November 7 at 5:22 PM
sfgate.com logoPersonalis: Q3 Earnings Snapshot
sfgate.com - November 7 at 5:22 PM
finance.yahoo.com logoPersonalis Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 7 at 5:22 PM
benzinga.com logoEarnings Outlook For Personalis
benzinga.com - November 6 at 3:36 PM
msn.com logoPersonalis start early access program for cancer detection blood test
msn.com - October 27 at 5:39 PM
finance.yahoo.com logoPersonalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
finance.yahoo.com - October 26 at 10:24 AM
finance.yahoo.com logoPersonalis to Announce Third Quarter 2023 Financial Results
finance.yahoo.com - October 24 at 7:56 PM
finance.yahoo.com logoAnalysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
finance.yahoo.com - October 21 at 7:57 AM
finance.yahoo.com logoPersonalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
finance.yahoo.com - October 19 at 8:46 AM
finance.yahoo.com logoPersonalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
finance.yahoo.com - October 18 at 9:12 AM
Get Personalis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

PSNL Media Mentions By Week

PSNL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PSNL
News Sentiment

0.00

0.48

Average
Medical
News Sentiment

PSNL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PSNL Articles
This Week

0

1

PSNL Articles
Average Week

Get Personalis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PSNL) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners